Parmax Pharma

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE240T01014
  • NSEID:
  • BSEID: 540359
INR
135.10
0.00 (0.00%)
BSENSE

Nov 20

BSE+NSE Vol: 5.33 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryParmax Pharma VS Pharmaceuticals & Biotechnology
 
1D
0%
1.08%
1W
0.07%
2.85%
1M
-0.95%
13.63%
YTD
299.35%
-1.53%
1Y
323.51%
-2%
3Y
320.22%
27.82%
5Y
229.51%
40.72%
10Y
%
220.91%
  • Stock Absolute Returns
  • Absolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
6.04%
0%
6.04%
6 Months
298.64%
0%
298.64%
1 Year
323.51%
0%
323.51%
2 Years
175.83%
0%
175.83%
3 Years
320.22%
0%
320.22%
4 Years
266.12%
0%
266.12%
5 Years
229.51%
0%
229.51%

Parmax Pharma for the last several years.

stock-summaryReturn Quartiles
What is a Quartile?

Quartile analysis gives a quick view of the performance of the stock with its peers and with the overall market. Companies are bucketed in 4 Quartiles as per their total returns generated; with each quartile consisting of 25% of the companies in the category.


Example: If there are 20 companies in an industry, the top 5 return giving companies would be bucketed in 1st quartile, next 5 companies in 2nd quartile and so on

Return Quartiles - by Closest Peers stock-summary
Icon
Not enough Stock Price history for Quartile Analysis
Return Quartiles - by Industry stock-summary
Icon
Not enough Stock Price history for Quartile Analysis
Return Quartiles - by Market Cap stock-summary
Icon
Not enough Stock Price history for Quartile Analysis
stock-summaryRisk Adjusted Returns v/s
Risk Adjusted Returns v/s stock-summary
stock-summaryReturns Beta
Returns Beta
Icon
Beta has not been calculated since enough price history is not available